Publication: Surgical orthopedic correction of hemophilic hemarthrosis at Ramathibodi Hospital.
Issued Date
1993-12-01
Resource Type
ISSN
01251562
Other identifier(s)
2-s2.0-0027902213
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Southeast Asian journal of tropical medicine and public health. Vol.24 Suppl 1, (1993), 253-255
Suggested Citation
P. Isarangkura, S. Keorochana, A. Chuansumrit, C. Jitpraphai, W. Mahaphan, P. Hathirat, P. Chiewsilp, P. Prachathumrong, P. Pintadit, W. Panthangkura Surgical orthopedic correction of hemophilic hemarthrosis at Ramathibodi Hospital.. The Southeast Asian journal of tropical medicine and public health. Vol.24 Suppl 1, (1993), 253-255. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/22657
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Surgical orthopedic correction of hemophilic hemarthrosis at Ramathibodi Hospital.
Other Contributor(s)
Abstract
During 1982-1992, 15 major surgical orthopedic correction (SOC) were performed in 12 hemophiliacs. There were 11 synovectomy, 2 osteotomy, 1 currettage and suture wound, 1 release of multiple joint contracture and 1 removal of pseudotumour. During 1982-1989, frozen cryoprecipitate was entirely used for replacement therapy in 5 cases who had 7 SOC. During 1990-1992, 7 cases received SOC by using factor VIII concentrate (Emoclot or Profilate) alone or combined with cryoprecipitate in 8 SOC. Multiple surgical procedures could be performed by using factor VIII concentrates. The orthopedist could operate 3 joints in one setting ie right knee, left knee and right middle finger. There are many advantages of factor VIII concentrates over those of cryoprecipitate, especially in the aspect of HIV transmission by HIV seronegative blood products. The disadvantage is the extremely high cost of factor concentrates.